- Arcus Biosciences Announces New Employment Inducement Grants
- Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update
- Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024
- Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting
- Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update
- Arcus Biosciences to Participate in Two Upcoming Investor Conferences
- Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update
More ▼
Key statistics
On Friday, Arcus Biosciences Inc (RCUS:NYQ) closed at 16.71, 29.03% above the 52 week low of 12.95 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 16.21 |
---|---|
High | 17.95 |
Low | 16.21 |
Bid | 16.20 |
Offer | 17.77 |
Previous close | 16.15 |
Average volume | 547.33k |
---|---|
Shares outstanding | 90.95m |
Free float | 53.82m |
P/E (TTM) | -- |
Market cap | 1.47bn USD |
EPS (TTM) | -3.10 USD |
Data delayed at least 15 minutes, as of May 10 2024 21:10 BST.
More ▼